Cafepharma Today

January 29 2025 - How might the FDA evolve under RFK Jr. and Makary?
How might the FDA evolve under RFK Jr. and Makary?
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Teva Pharmaceutical posts lower revenue
Troubled 23andMe is exploring a sale of the business
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

No Black Box for Antiepileptics
Invivo
Wednesday, November 26, 2008 - 8:31am
tags:
Genzyme seeks FDA approval to treat adult leukemia
Bizjournals.com
Wednesday, November 26, 2008 - 8:29am
tags:
AstraZeneca maintains 2008 profit forecast
Yahoo/AP
Wednesday, November 26, 2008 - 8:28am
tags:
See You Next Year, Generic Pulmicort Respules
WSJ Online
Wednesday, November 26, 2008 - 8:27am
tags:
Johnson & Johnson gets FDA rejection letter over antibiotic-resistant infection treatment
Yahoo/AP
Wednesday, November 26, 2008 - 8:26am
tags:
Trial Results Don't Look Good for GlaxoSmithKline's Diabetes Drug
Seeking Alpha
Wednesday, November 26, 2008 - 8:26am
tags:
Inhaled steroids up pneumonia risk in lung ailment
Yahoo/Reuters
Wednesday, November 26, 2008 - 8:25am
tags:
The Clock Is Ticking on Big Pharma Mergers
WSJ Online
Wednesday, November 26, 2008 - 7:37am
tags:
Risperdal Can Have Troubling Side Effects in Boys
WSJ Online
Wednesday, November 26, 2008 - 7:37am
tags:
Bayer to Pay $97.5 Million to Settle Kickback Claim
Bloomberg
Wednesday, November 26, 2008 - 7:36am
tags:
Roche Reduces Price of Tarceva for U.K. Lung-Cancer Patients
Bloomberg
Wednesday, November 26, 2008 - 7:36am
tags:
AstraZeneca settles asthma drug lawsuit with Teva
Marketwatch
Tuesday, November 25, 2008 - 3:44pm
tags:
Somaxon Likely Headed Below $1
Yahoo/Zacks.com
Tuesday, November 25, 2008 - 3:43pm
tags:
Schering-Plough: The Reviews Are In
CNBC
Tuesday, November 25, 2008 - 3:42pm
tags:
Cephalon pays ImmuPharma $15 million for option deal on rights to developing lupus drug
Yahoo/AP
Tuesday, November 25, 2008 - 3:41pm
tags:
Wall Street sees stronger King Pharmaceuticals following $1.6 billion deal to buy Alpharma
Yahoo/AP
Tuesday, November 25, 2008 - 9:34am
tags:
Allos Therapeutics' cancer drug gets FDA's orphan designation, providing market exclusivity
Yahoo/AP
Tuesday, November 25, 2008 - 9:11am
tags:
Exelixis wins $20 million in Bristol-Myers Squibb deal
Bizjournals.com
Tuesday, November 25, 2008 - 9:10am
tags:
Memory selling to partner Roche for $50 million
Yahoo/AP
Tuesday, November 25, 2008 - 7:56am
tags:
Achillion Pharma: Hepatitis Drug Dev Pipeline Now Fully Funded
Seeking Alpha
Tuesday, November 25, 2008 - 7:55am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information